Medipharm Labs Corp Stock Price Prediction
| LABS Stock | CAD 0.09 0.01 5.88% |
Momentum 58
Buy Extended
Oversold | Overbought |
Wall Street Target Price 0.1 | Quarterly Revenue Growth 0.152 |
Using Medipharm Labs hype-based prediction, you can estimate the value of Medipharm Labs Corp from the perspective of Medipharm Labs response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medipharm Labs to buy its stock at a price that has no basis in reality. In that case, they are not buying Medipharm because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Medipharm Labs after-hype prediction price | CAD 0.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medipharm |
Medipharm Labs After-Hype Price Prediction Density Analysis
As far as predicting the price of Medipharm Labs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medipharm Labs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medipharm Labs, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Medipharm Labs Estimiated After-Hype Price Volatility
In the context of predicting Medipharm Labs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medipharm Labs' historical news coverage. Medipharm Labs' after-hype downside and upside margins for the prediction period are 0.00 and 5.85, respectively. We have considered Medipharm Labs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Medipharm Labs is out of control at this time. Analysis and calculation of next after-hype price of Medipharm Labs Corp is based on 3 months time horizon.
Medipharm Labs Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Medipharm Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medipharm Labs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medipharm Labs, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.82 | 5.76 | 0.00 | 0.01 | 2 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.09 | 0.09 | 0.00 |
|
Medipharm Labs Hype Timeline
Medipharm Labs Corp is now traded for 0.09on Toronto Exchange of Canada. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Medipharm is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at 0.82%. %. The volatility of related hype on Medipharm Labs is about 38400.0%, with the expected price after the next announcement by competition of 0.10. The company has price-to-book ratio of 0.82. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medipharm Labs Corp has Price/Earnings (P/E) ratio of 172.0. The entity recorded a loss per share of 0.03. The firm had not issued any dividends in recent years. Medipharm Labs had 1:2 split on the 4th of October 2018. Assuming the 90 days trading horizon the next estimated press release will be in a few days. Check out Medipharm Labs Basic Forecasting Models to cross-verify your projections.Medipharm Labs Related Hype Analysis
Having access to credible news sources related to Medipharm Labs' direct competition is more important than ever and may enhance your ability to predict Medipharm Labs' future price movements. Getting to know how Medipharm Labs' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medipharm Labs may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OGI | OrganiGram Holdings | 0.05 | 5 per month | 0.00 | (0.12) | 5.22 | (6.80) | 25.08 | |
| CWEB | Charlottes Web Holdings | (0.02) | 1 per month | 5.20 | 0.02 | 14.29 | (11.11) | 35.42 |
Medipharm Labs Additional Predictive Modules
Most predictive techniques to examine Medipharm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medipharm using various technical indicators. When you analyze Medipharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Medipharm Labs Predictive Indicators
The successful prediction of Medipharm Labs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medipharm Labs Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medipharm Labs based on analysis of Medipharm Labs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medipharm Labs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medipharm Labs's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 214.62 | 64.76 | 74.47 | 70.75 | PTB Ratio | 0.35 | 0.45 | 0.51 | 0.49 |
Story Coverage note for Medipharm Labs
The number of cover stories for Medipharm Labs depends on current market conditions and Medipharm Labs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medipharm Labs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medipharm Labs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Medipharm Labs Short Properties
Medipharm Labs' future price predictability will typically decrease when Medipharm Labs' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Medipharm Labs Corp often depends not only on the future outlook of the potential Medipharm Labs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medipharm Labs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 363.3 M | |
| Cash And Short Term Investments | 18 M |
Other Information on Investing in Medipharm Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.